270 related articles for article (PubMed ID: 18435932)
1. Human alpha-defensins inhibit Clostridium difficile toxin B.
Giesemann T; Guttenberg G; Aktories K
Gastroenterology; 2008 Jun; 134(7):2049-58. PubMed ID: 18435932
[TBL] [Abstract][Full Text] [Related]
2. Defensins versus bacteria: not just antibiotics anymore.
Salzman NH
Gastroenterology; 2008 Jun; 134(7):2174-7. PubMed ID: 18486618
[No Abstract] [Full Text] [Related]
3. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
4. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
[TBL] [Abstract][Full Text] [Related]
5. Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro.
Schlegel N; Meir M; Spindler V; Germer CT; Waschke J
J Cell Physiol; 2011 May; 226(5):1196-203. PubMed ID: 20945370
[TBL] [Abstract][Full Text] [Related]
6. Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins.
Lehrer RI; Jung G; Ruchala P; Wang W; Micewicz ED; Waring AJ; Gillespie EJ; Bradley KA; Ratner AJ; Rest RF; Lu W
Infect Immun; 2009 Sep; 77(9):4028-40. PubMed ID: 19581399
[TBL] [Abstract][Full Text] [Related]
7. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
[TBL] [Abstract][Full Text] [Related]
8. Human α-Defensin-6 Neutralizes
Barthold L; Heber S; Schmidt CQ; Gradl M; Weidinger G; Barth H; Fischer S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562899
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
Zeiser J; Gerhard R; Just I; Pich A
J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
[TBL] [Abstract][Full Text] [Related]
10. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.
Kreimeyer I; Euler F; Marckscheffel A; Tatge H; Pich A; Olling A; Schwarz J; Just I; Gerhard R
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):253-62. PubMed ID: 21046073
[TBL] [Abstract][Full Text] [Related]
11. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Jank T; Giesemann T; Aktories K
Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
[TBL] [Abstract][Full Text] [Related]
12. Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins.
Kudryashova E; Quintyn R; Seveau S; Lu W; Wysocki VH; Kudryashov DS
Immunity; 2014 Nov; 41(5):709-21. PubMed ID: 25517613
[TBL] [Abstract][Full Text] [Related]
13. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.
Schirmer J; Aktories K
Biochim Biophys Acta; 2004 Jul; 1673(1-2):66-74. PubMed ID: 15238250
[TBL] [Abstract][Full Text] [Related]
14. Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.
Halabi-Cabezon I; Huelsenbeck J; May M; Ladwein M; Rottner K; Just I; Genth H
FEBS Lett; 2008 Nov; 582(27):3751-6. PubMed ID: 18848548
[TBL] [Abstract][Full Text] [Related]
15. EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.
Majumder S; Schmidt G; Lohia A; Aktories K
Appl Environ Microbiol; 2006 Dec; 72(12):7842-8. PubMed ID: 17056697
[TBL] [Abstract][Full Text] [Related]
16. Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.
Sehr P; Joseph G; Genth H; Just I; Pick E; Aktories K
Biochemistry; 1998 Apr; 37(15):5296-304. PubMed ID: 9548761
[TBL] [Abstract][Full Text] [Related]
17. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
18. Protection from Clostridium difficile toxin B-catalysed Rac1/Cdc42 glucosylation by tauroursodeoxycholic acid-induced Rac1/Cdc42 phosphorylation.
Brandes V; Schelle I; Brinkmann S; Schulz F; Schwarz J; Gerhard R; Genth H
Biol Chem; 2012 Jan; 393(1-2):77-84. PubMed ID: 22628301
[TBL] [Abstract][Full Text] [Related]
19. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences.
Kim C; Gajendran N; Mittrücker HW; Weiwad M; Song YH; Hurwitz R; Wilmanns M; Fischer G; Kaufmann SH
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4830-5. PubMed ID: 15772169
[TBL] [Abstract][Full Text] [Related]
20. Impact of amino acids 22-27 of Rho-subfamily GTPases on glucosylation by the large clostridial cytotoxins TcsL-1522, TcdB-1470 and TcdB-8864.
Müller S; von Eichel-Streiber C; Moos M
Eur J Biochem; 1999 Dec; 266(3):1073-80. PubMed ID: 10583404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
